JEMI vs. WWH, ATT, WTAN, BRW, SNN, BHMU, PIN, JTC, VEIL, and FGT
Should you be buying JPMorgan Global Emerg Mkts stock or one of its competitors? The main competitors of JPMorgan Global Emerg Mkts include Worldwide Healthcare (WWH), Allianz Technology Trust (ATT), Witan Investment Trust (WTAN), Brewin Dolphin (BRW), Sanne Group (SNN), BH Macro USD (BHMU), Pantheon International (PIN), JTC (JTC), Vietnam Enterprise (VEIL), and Finsbury Growth & Income (FGT). These companies are all part of the "asset management" industry.
JPMorgan Global Emerg Mkts vs. Its Competitors
JPMorgan Global Emerg Mkts (LON:JEMI) and Worldwide Healthcare (LON:WWH) are both small-cap financial services companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, media sentiment, risk, analyst recommendations, earnings, dividends and profitability.
JPMorgan Global Emerg Mkts pays an annual dividend of GBX 5 per share and has a dividend yield of 3.4%. Worldwide Healthcare pays an annual dividend of GBX 3 per share and has a dividend yield of 1.0%. JPMorgan Global Emerg Mkts pays out 56.6% of its earnings in the form of a dividend. Worldwide Healthcare pays out 7.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.
Worldwide Healthcare has a net margin of 92.78% compared to JPMorgan Global Emerg Mkts' net margin of 72.95%. Worldwide Healthcare's return on equity of 11.22% beat JPMorgan Global Emerg Mkts' return on equity.
Worldwide Healthcare has higher revenue and earnings than JPMorgan Global Emerg Mkts. Worldwide Healthcare is trading at a lower price-to-earnings ratio than JPMorgan Global Emerg Mkts, indicating that it is currently the more affordable of the two stocks.
In the previous week, JPMorgan Global Emerg Mkts and JPMorgan Global Emerg Mkts both had 2 articles in the media. Worldwide Healthcare's average media sentiment score of 1.37 beat JPMorgan Global Emerg Mkts' score of 0.55 indicating that Worldwide Healthcare is being referred to more favorably in the news media.
56.3% of JPMorgan Global Emerg Mkts shares are held by institutional investors. Comparatively, 73.6% of Worldwide Healthcare shares are held by institutional investors. 3.7% of JPMorgan Global Emerg Mkts shares are held by company insiders. Comparatively, 0.4% of Worldwide Healthcare shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Summary
Worldwide Healthcare beats JPMorgan Global Emerg Mkts on 8 of the 13 factors compared between the two stocks.
Get JPMorgan Global Emerg Mkts News Delivered to You Automatically
Sign up to receive the latest news and ratings for JEMI and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding JEMI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
JPMorgan Global Emerg Mkts Competitors List
Related Companies and Tools
This page (LON:JEMI) was last updated on 7/4/2025 by MarketBeat.com Staff
